Clinical Trial Update: A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer [NA]

View source ↗

Summary

A Phase II trial evaluating an organ-conserving radiochemotherapy approach for muscle-invasive bladder cancer has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer
• Urothelial Carcinoma of the Bladder

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Infiltrating Bladder Urothelial Carcinoma | NA | Status: TERMINATED | Results posted: 2025-10-10